Murphy & Mullick Capital Management Corp Dr Reddys Laboratories LTD Transaction History
Murphy & Mullick Capital Management Corp
- $109 Billion
- Q4 2024
A detailed history of Murphy & Mullick Capital Management Corp transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Murphy & Mullick Capital Management Corp holds 1,500 shares of RDY stock, worth $20,700. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,500Holding current value
$20,700% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding RDY
# of Institutions
258Shares Held
59.4MCall Options Held
12.7KPut Options Held
6.1K-
Robeco Institutional Asset Management B.V.11.4MShares$158 Million0.35% of portfolio
-
Aikya Investment Management LTD London, X05.61MShares$77.4 Million36.88% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.9MShares$67.6 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.81MShares$38.8 Million0.0% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa2.47MShares$34.1 Million0.02% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.29B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...